Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
9 drugs across 3 manufacturers|0 Generic,9 Brand
The Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class contains 9 NDCs from 3 manufacturers (0 generic, 9 brand), at an average NADAC of $100.28 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
9
0G / 9B
Manufacturers
3
Avg $100.2786/unit
Avg 7d Change
+0.06%
Across 9 drugs with changes
7d Activity
of 9 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
3 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
STRIBILD TABLET elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | $150.1432 per EA | +0.27% |
GENVOYA TABLET elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide | $143.3532 per EA | +0.02% |
TRIUMEQ 600-50-300 MG TABLET abacavir sulfate, dolutegravir sodium, lamivudine | $130.0062 per EA | -0.10% |
JULUCA 50-25 MG TABLET dolutegravir sodium and rilpivirine hydrochloride | $121.8664 per EA | -0.01% |
DOVATO 50-300 MG TABLET dolutegravir sodium and lamivudine | $105.2246 per EA | +0.18% |
DOVATO 50-300 MG TABLET dolutegravir sodium and lamivudine | $105.2246 per EA | +0.18% |
TIVICAY 50 MG TABLET dolutegravir sodium | $77.6356 per EA | +0.06% |
ISENTRESS 400 MG TABLET RALTEGRAVIR | $34.5389 per EA | -0.01% |
ISENTRESS HD 600 MG TABLET RALTEGRAVIR | $34.5150 per EA | +0.03% |
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
ViiV Healthcare Company manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
dolutegravir sodium and lamivudine market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class?
The Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class contains 9 NDCs from 3 manufacturers — 0 generic and 9 brand products.
What is the average price of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs?
The average NADAC for the Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class is $100.2786 per unit across 9 NDCs.
Which manufacturers make Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs?
3 manufacturers make drugs in the Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class. Ranked by number of NDCs, the largest are ViiV Healthcare Company (5), Gilead Sciences, Inc. (2), Merck Sharp & Dohme LLC (2).
How has Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor pricing changed recently?
Over the past 7 days, 6 NDCs in this class rose and 3 fell, with a class-wide average change of +0.1%.